학술논문

Immunogenicity Parameters of Cancer Patients Receiving the mRNA Vaccine BNT162b2 While Obtaining Radiotherapy: A Longitudinal Cohort Evaluation.
Document Type
Article
Source
Vaccines; Mar2024, Vol. 12 Issue 3, p275, 14p
Subject
MEDICAL personnel
IMMUNE response
CANCER patients
COVID-19 pandemic
COVID-19 vaccines
PURE red cell aplasia
Language
ISSN
2076393X
Abstract
Copyright of Vaccines is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)